December 2014 Functional Medicine Update

Well, here we are once again at the end of Functional Medicine Update Year, the year of 2014. I cannot believe we're into our December issue. First of all, happy holidays wherever you are, whatever you're doing. I hope this is a time of great cheer, family and friends and really just celebrating this extraordinary year that we've just had the privilege of living through. And obviously looking forward to what 2015 will bring. And I can assure you that 2015 in function medicine Update is going to mean lots of interesting things. We already have them planned and we're going, we're working on them to make them real. I was very pleased the feedback we got in 2014 from many of you that this was the best year we've ever had in terms of the interviews and the focus that we had in our interviews and the kind of news to use that was brought forward. So thanks so much for your participation and your support and your feedback. We appreciate it very, very much. So this December issue is the culmination of a three part series, as you know, in insulin resistance, type 2 diabetes and the multiform ways that this expresses itself into diseases from renal failure to ocular to neurological problems and cardiometabolic disease and diabesity. And we're very, very privileged in our December 3rd issue of 3rd edition of this Focus to have Dr. C. Ron Khan, who is arguably one of the world's foremost insulin researchers and diabetes researchers, director of the Joslin Diabetes Research foundation and Clinic at Harvard Medical School. And I think you're going to find he will share with you information that you can't find anywh else. It's just really powerful news to use that kind of wraps together what we've already heard from Dr. Philip Kern and Dr. Osama Hamdi in our previous edition. So this three part series, we have got a great close for you this month with Dr. Khan. Thanks for being with us this year.